Pharmaceutical Industry Information Portal

HomeNews

News

FDA Authorizes Additional COVID-19 Vaccine Dose for Certain Immunocompromised Individuals

The FDA evaluated information on the use of a third dose of the Pfizer-BioNTech or Moderna Vaccines and determined that the administration of third vaccine doses may increase protection in this population.

BratskChemSyntez and Reshetnev Siberian State University developed a training program for synthesis operators

The plant technologists and University teachers took part in the development. It will give a deeper understanding of the organic synthesis manufacturing process and...

Moderna and Canada Announce Collaboration to Bring mRNA Manufacturing

The collaboration aims to provide Canadians with access to a domestically manufactured portfolio of mRNA vaccines against respiratory viruses, including COVID-19, seasonal influenza...

WHO’s Solidarity clinical trial enters a new phase with three new candidate drugs

The Solidarity PLUS trial is a platform trial that represents the largest global collaboration among WHO Member States.

Laboratorios Richmond delivers the first batch of over 1M doses of the Sputnik V produced in Argentina

Locally produced Sputnik V was supervised and verified by the National Administration of Drugs, Foods and Medical Devices of Argentina (ANMAT).

Official data from leading countries confirms the Sputnik V vaccine’s high safety and efficacy profile

To date Sputnik V has been approved in 69 countries with total population exceeding 3.7 billion people - nearly half of the global population.
spot_img

Expert Articles

spot_img